Outstanding 👏 work by Duke Surgical Oncology Jennifer Plichta MD (she/her). Novel 💡 staging model for de novo metastatic #BreastCancer. #Novel #Impactful Journal of Clinical Oncology 2023 ➡️ now validated in an international cohort of 5️⃣ countries 🇫🇷 🇲🇽 🇳🇱 🇨🇦 🇪🇸

An excellent ASBrS Annual Meeting Scientific Committee meeting at #ASBrS24 led by Sarah L. Blair & @drmediget! Looking forward to the scientific presentations! LauraRosenbergerMD Doreen Agnese Anna Weiss Preeti Subhedar, MD Olga Kantor MD, MS, FACS Marissa Howard-McNatt, MD T. Salewa Oseni, MD…

Ready for a great day at #ASBrS24! And can I just say a heartfelt thank you to ASBrS for a caffeinated coffee alternative for us non-coffee drinkers?

Great talk on the use of MRI in beast cancer. There are some appropriate uses but it should not be used routinely in the preoperative work up of breast cancer. ASBrS #ASBRS24

Great talk about personalizing radiation care from a familiar face to the osu team! Julia White

Excellent discussion of genetic panel testing by @jenniferplichta. The key is shared decision making. #asbrs24

Are we ready for the ultimate breast conservation? More data to come!

Should we exclude anyone from cancer genetic testing? Dr. Euhus says “No” We should be thoughtful about how we use genetic mutation information combined with other risk factors for breast cancer screening and risk reduction. #ASBrS24

Key considerations in how genetic variants affect care by Vivian J. Bea, MD, MBS, FACS, eMBA/MS (c) #ASBrS24 ASBrS

Important presentation by Alexa Glencer highlighting NON-guideline concordant care of IBC. In the era of de-escalation, education is needed to avoid non-data backed care. All IBC pts need trimodal therapy with modified radical mastectomy! ASBrS MD Anderson Cancer Center #ASBrS24

Excellent Canadian 🇨🇦 study on young women w/#BreastCancer by Katherine Fleshner 👏. Healthcare system working well and opportunities to educate young women re: signs/symptoms of breast cancer. ASBrS #ASBrS24

Interesting presentation by Katherine Fleshner on diagnostic delays in young pts - primarily patient delays vs system delays highlighting the need for provider & pt education on recognizing signs and symptoms which may be different in this population #ASBrS24 ASBrS

So proud of Alex Moore highlighting the clinical implications of cALND in pts with +TAD. 45% had ⬆️RCB from additional disease on cALND. No data yet to support oncologic safety of omitting cALND for +TAD. MD Anderson Cancer Center @drmediget ASBrS #ASBrS24 #precisionmatters

Very interesting study by Anna Weiss regarding genetic testing for surgical decision making. We need to change the way we test as we increase the number of patients tested and assure our patients really understand their future risks of contralateral cancer. #asbrs24 ASBrS

👏👏Excellent overview by Akiko Chiba, MD, FACS on how social media may impact health outcomes!!🧐🧐 Physician education, patient education, public health notifications, counter misinformation, and more!! 🙌🙌 #ASBRS24

Can AI help us to transition to a system where disease is prevented rather than treated? #asbrs24

Dog or Muffin? #AI #ASBrS24

Always amazing! How does she do it every year! #asbrs24

Updates from San Antonio. The key word is de-escalation. #asbrs24

Even after fellowship the mentoring continues!